- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Ediscovery
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Litigation Support Services
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
-
January 15, 2021Robins Kaplan Partners Named to IAM Strategy 300 Global Leaders Guide
-
January 12, 20212025 Goals - Our commitment to Inclusion, Diversity, and Equity
-
January 5, 2021Litigator Mark Hallberg Joins Robins Kaplan LLP
-
January 28, 2021COVID-19: The Show Did Not Go On
-
February 9, 2021Smart Phone Privacy and Data Security – How to Assess and Minimize Risk in the Current Reality
-
March 6, 2021With Our Voices 2021 Arc Gala
-
December 27, 2020Covid-19 Relief Bill Provides Long-Awaited Funding to Small Businesses and Individuals
-
December 17. 2020Covid-19 Divorce and Marital Property Agreements
-
Fall 2020COVID Immunity: No, Not That Kind of Immunity
-
January 22, 2021Financial Daily Dose 1.22.2021 | Top Story: Google Threatens to Pull Search From Down Under Over Proposed Law
-
January 21, 2021Financial Daily Dose 1.21.2021 | Top Story: Wall Street Greets Biden Administration With Rally, Records on Stimulus Hopes
-
January 20, 2021Financial Daily Dose 1.20.2021 | Top Story: Netflix Hits 200M Subscribers, Halts Massive Borrowing
Ortho Evra Patch for Birth-Control Exposes Women to High Estrogen Levels, Potential Risk of Dangerous Blood Clots
Ortho Evra Patch Lawsuit Information
November 22, 2005
Women who use the popular Ortho Evra patch for birth-control are exposed to as much as 60 percent more estrogen than women who use typical birth-control pills, according to a new warning issued by the drug’s manufacturer. High estrogen levels are associated with an increased risk of developing potentially fatal blood clots (strokes).
In a news release accompanying the November 10, 2005, announcement of the warning, the Food and Drug Administration stated that Ortho McNeil, the manufacturer of the Ortho Evra patch, currently is conducting studies to compare the risks of developing serious blood clots, in women using the Ortho Evra patch with the risks caused by typical birth control pills.[1]
An Associated Press investigation published in July 2005 reported that women on the Ortho Evra patch were three times more likely to die or be injured by a blood clot than women on the pill.[2] The AP report indicated that potential Ortho Evra patch deaths have been reported in about a dozen young women in 2004. [3] The report was based on an analysis of federal drug-safety reports from 2004. During that year, according to the Associated Press, annual American sales of the Ortho Evra patch reached an estimated $400 million. [4]
If you or someone you know has been injured or killed by a blood clot while using Ortho Evra patch and you wish to consult with us, please call our lawyers currently handling drug lawsuits: Gary Wilson at 612.349.8413 and Tara Sutton at 612.349.8577. You can also send them an e-mail by clicking on this link: contact us.
[2] Martha Mendoza, “Birth Control Patch May Have Higher Risk,” The Associated Press, July 16, 2005.
[3] Martha Mendoza, “Millions Spent on Birth-Control Patch Ads,” The Associated Press, July 16, 2005.
[4] Martha Mendoza, “Millions Spent on Birth-Control Patch Ads,” The Associated Press, July 16, 2005.
The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.
Related Professionals
Gary L. Wilson
Partner
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.